Spelling suggestions: "subject:"pharmacists’"" "subject:"harmacists’""
91 |
Pharmacists’ Perceptions of Patients’ Health Literacy Levels Compared to Measured Health Literacy LevelsMnatzaganian, Christina, Fabriguze, Angel, Phan, Tina, Lee, Jeannie January 2011 (has links)
Class of 2011 Abstract / OBJECTIVES: To compare pharmacists’ perceptions of patients’ health literacy levels to their measured health literacy levels.
METHODS: This was descriptive study that included thirty patients from two independent pharmacies where they were administered a health literacy survey at random during their routine visit to the pharmacy. Each participant’s health literacy assessment was scored and assigned to a corresponding literacy level. Pharmacists from each store were then surveyed as to what they perceived each patient’s health literacy level to be.
RESULTS: Twenty-eight of the thirty participants (93%) obtained the highest literacy score possible in the assessment. Two participants scored lower literacy levels and were both non-whites who were currently taking six or more medications and over the age of 50. No significant differences with respect to age, gender, education level, number of previous conversations with the pharmacist, or number of current medications were found as compared to measured literacy level. Actual literacy scores as well as perceived literacy levels between sites were also found to be insignificant (p=0.17 and p=0.58 respectively). With respect to race, there was a significant difference between whites vs. non-whites relative to REALM scores (p<0.001). Analysis of the difference between actual literacy scores and perceived scores were unable to be determined.
CONCLUSION: Based on the two participants who had lower literacy levels, this may suggest a disparity in health literacy with respect to race, age, and number of concurrent medications. However, due to lack of study variability, the significance of the difference was unable to be determined and conducting a larger study with more diverse settings, demographics, and larger sample size is suggested.
|
92 |
Assessment of Japanese Pharmacists’ Perceptions towards Community PharmacyOkumoto, Kaci, Sanagawa, Harumi January 2005 (has links)
Class of 2005 Abstract / Objectives: The objectives of this study were to 1) describe Japanese pharmacists’ perceptions about community pharmacy on a variety of issues and 2) compare the perceptions between different groups.
Methods: A questionnaire was administered to a convenience sample of community pharmacists in the Tokyo metropolitan area and Hiroshima prefecture. Pharmacists were surveyed on various issues such as job satisfaction, the separation of prescribing and dispensing, their relationship with patients and physicians, and pharmacy education. A five-point Likert scale was used to measure responses.
Results: One hundred forty-four questionnaires were completed. Eighty-four percent of respondents were female, 37.5% had more than ten years of practice experience, and 81.9% worked in Tokyo. Japanese community pharmacists are neutral or satisfied with their jobs. However, respondents were not satisfied with the current state of community pharmacy in Japan (2.81 + 0.83), did not feel respected by patients (2.74 + 0.99) and physicians (1.99 + 0.95), felt that four years of education was not enough to provide adequate patient care (1.96 + 1.01), and would like to do more clinical oriented activities (3.77 + 0.84). Significant differences were found in some responses between groups such as males versus females and pharmacists with more versus less than ten years of practice experience.
Conclusions: Respondents were not satisfied with the current state of community pharmacy in Japan. Areas that could use improvement are respect from patients and physicians, involvement in clinical activities, and assistance at work. Significant differences were found in the perceptions of the groups studied.
|
93 |
Creation, Delivery, and Evaluation of a Malignant Melanoma Continuing Education Program for PharmacistsCooley, Janet, Gunderson, Lisa, Tate, Jacqueline January 2006 (has links)
Class of 2006 Abstract / Objectives: To create, deliver, and evaluate a malignant melanoma continuing education (CE) seminar for pharmacists.
Methods: A CE program was developed and presented to educate pharmacists about skin cancer prevention, specifically malignant melanoma, and their role in prevention through patient counseling. All practicing pharmacists who attended the CE program were asked to fill out a knowledge indicator and assess their comfort level in counseling patients about sun safety before and after the program. The participants also answered questions addressing how often they counsel patients on sunscreen use, their personal experience with skin cancer, preferred CE format, previous CE attendance, sex, age, practice site, hours worked per week, and years since graduation from pharmacy school.
Results: The survey instrument was completed by 84 pharmacists. The average score on the pre-test knowledge indicator was 4.95 ± 0.39 and the average score on the post-test knowledge indicator was 7.81 ± 0.39. This was a significant improvement (p < 0.01). There was a significant increase in participant comfort level when counseling patients about sun safety after attending the CE program (p < 0.01). Personal experience with skin cancer did not have a significant effect on the pre-test knowledge indicator scores, however it was associated with the knowledge indicator change score (p < 0.01). Completion of previous skin cancer CE programs did not have a significant effect on the pre-test knowledge indicator score or the change score.
Conclusions: Pharmacists who attended the CE program improved their knowledge indicator scores when tested about malignant melanoma and sun safety. Many participants felt more comfortable counseling patients about sun safety and felt their counseling on sun safety would change as a result of attending this CE program.
|
94 |
Clinical pharmacists in primary care: a safe solution to the workforce crisis?Komwong, D., Greenfield, G., Zaman, Hadar, Majeed, A., Hayhoe, B. 2018 February 1926 (has links)
No
|
95 |
What is the role of the employer in the development of management skills in the pharmacy profession (Spain)Breen, Liz, Acosta-Gómez, J. 09 1900 (has links)
No
|
96 |
A Pharmacist view of the impact/management of medicines shortages (MedS) in the pharmaceutical supply chain (Spain)Sai Reddy Jetty, V., Breen, Liz, Acosta Gomez, J. 20 July 2021 (has links)
Yes
|
97 |
Evaluating Team-Based Learning in a foundation training for trainee pharmacistsMedlinskiene, Kristina, Hill, S., Tweddell, Simon, Quinn, Gemma L. 08 May 2023 (has links)
No
|
98 |
The effectiveness of pharmacist interventions in improving asthma control and quality of life in patients with difficult asthmaCapstick, Toby Gareth David January 2014 (has links)
Despite national guidelines, the management of difficult asthma remains suboptimal, and there may be opportunities for pharmacists to improve asthma outcomes. This six-month prospective, randomised, open study investigated the effects of pharmaceutical care across primary and secondary care on difficult asthma. Fifty-two patients attending a hospital difficult asthma clinic were randomised (1:1) to receive usual medical care (UC), or pharmacist interventions (PI) comprising asthma review, education, and medicines optimisation from a hospital advanced clinical pharmacist, plus follow-up targeted Medicines Use Review (t-MUR) from community pharmacists. Forty-seven patients completed the study. More interventions were performed in the PI group at baseline (total 79 vs. 34, p<0.001), but only six patients received a t-MUR. At six-months, PI were non-inferior to UC for all outcomes. The primary outcome measure was Juniper’s Asthma Control Questionnaire score and reduced (improved) from a median (IQ) score of 2.86 (2.25, 3.25) and 3.00 (1.96, 3.71) in the PI and UC groups respectively to 2.57 (1.75, 3.67) and 2.29 (1.50, 3.50). At baseline, 58.8%, 46.9% and 17.6% of patients had optimal inhaler technique using Accuhalers, Turbohalers or pMDIs; education improved technique but this was not maintained at six-months. Adherence rates < 80% were observed in 57.5% of patients at baseline, and was improved in the PI group at six-months (10/20 PI vs. 3/21 UC had adherence rates of 80-120%, p=0.020). This study demonstrates that the management of difficult asthma by specialist pharmacists is as effective as usual medical care. Future research should investigate whether pharmacist-led follow-up produces further improvements.
|
99 |
The Effectiveness of Pharmacist Interventions in Improving Asthma Control and Quality of Life in Patients with Difficult AsthmaCapstick, Toby G.D. January 2014 (has links)
Despite national guidelines, the management of difficult asthma remains suboptimal, and there may be opportunities for pharmacists to improve asthma outcomes. This six-month prospective, randomised, open study investigated the effects of pharmaceutical care across primary and secondary care on difficult asthma.
Fifty-two patients attending a hospital difficult asthma clinic were randomised
(1:1) to receive usual medical care (UC), or pharmacist interventions (PI) comprising asthma review, education, and medicines optimisation from a hospital advanced clinical pharmacist, plus follow-up targeted Medicines Use Review (t-MUR) from community pharmacists.
Forty-seven patients completed the study. More interventions were performed in the PI group at baseline (total 79 vs. 34, p<0.001), but only six patients received a t-MUR. At six-months, PI were non-inferior to UC for all outcomes. The primary outcome measure was Juniper’s Asthma Control Questionnaire score and reduced (improved) from a median (IQ) score of 2.86 (2.25, 3.25) and 3.00 (1.96, 3.71) in the PI and UC groups respectively to 2.57 (1.75, 3.67) and 2.29 (1.50, 3.50).
At baseline, 58.8%, 46.9% and 17.6% of patients had optimal inhaler technique using Accuhalers, Turbohalers or pMDIs; education improved technique but this was not maintained at six-months. Adherence rates <80% were observed in 57.5% of patients at baseline, and was improved in the PI group at six-months (10/20 PI vs. 3/21 UC had adherence rates of 80-120%, p=0.020).
This study demonstrates that the management of difficult asthma by specialist pharmacists is as effective as usual medical care. Future research should investigate whether pharmacist-led follow-up produces further improvements. / The Pharmaceutical Trust for Educational and Charitable Objects (PTECO) (now known as Pharmacy Research UK).
|
100 |
Community pharmacists’ experience and perceptions of the New Medicines Service (NMS)Lucas, Beverley J., Blenkinsopp, Alison 25 February 2015 (has links)
Yes / Objectives The New Medicines Service (NMS) is provided by community pharmacists
in England to support patient adherence after the initiation of a new treatment.
It is provided as part of the National Health Service (NHS) pharmacy contractual
framework and involves a three-stage process: patient engagement, intervention and
follow-up. The study aims to explore community pharmacists’ experiences and perceptions
of NMS within one area of the United Kingdom.
Methods In-depth semi-structured telephone interviews were conducted with 14
community pharmacists. Interviews were audio-recorded, independently transcribed
and thematically analysed.
Key findings Pharmacists gave a mixed response to the operationalisation, ranging
from positive opportunities for improving adherence and enhancement of practice
to difficulties in terms of its administration. Pharmacists generallywelcomed opportunities
to utilise their professional expertise to achieve better patient engagement
and for pharmacy practice to develop as a patient resource. There was a perceived
need for better publicity about the service. Different levels of collaborative working
were reported. Some pharmacists were working closely with local general practices
most were not. Collaboration with nurses in the management of long-term conditions
was rarely reported but desired by pharmacists. Where relationships with
general practitioners (GPs) and nurses were established, NMS was an opportunity
for further collaboration; however, others reported a lack of feedback and recognition
of their role.
Conclusions Community pharmacists perceived the NMS service as beneficial to
patients by providing additional advice and reassurance, but perceptions of its
operationalisation were mixed.Overall, our findings indicate that NMS provides an
opportunity for patient benefit and the development of contemporary pharmacy
practice, but better collaboration with GPs and practice nurses could enhance the
service.
|
Page generated in 0.0445 seconds